Physician profile
Arvind J Bali
NPI 1053340935
$315.71
in general payments reported to CMS, 2019-2025
12 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.75 · 2020: $32.24 · 2021: $76.04 · 2022: $26.33 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $162.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $70.12 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.91 | 2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $32.24 | 2019-2020 | |
| Pfizer INC. | $27.40 | 2022-2025 | |
| Philips North America LLC | $22.90 | 2025 | Extended Holter |
| Edwards Lifesciences Corporation | $20.43 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $19.32 | 2025 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $18.83 | 2025 | |
| Biotronik INC. | $18.75 | 2020 | |
| Alnylam Pharmaceuticals INC. | $18.59 | 2025 | Amvuttra |
| Cvrx, INC. | $16.41 | 2025 | Barostim Neo System |
| Boston Scientific Corporation | $15.81 | 2025 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arvind Bali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.